ADHD - A TRANSPARENT IMPAIRMENT, CLINICAL, DAILY-LIFE AND RESEARCH ASPECTS IN DIVERSE POPULATIONS

ADHD - A TRANSPARENT IMPAIRMENT, CLINICAL, DAILY-LIFE AND RESEARCH ASPECTS IN DIVERSE POPULATIONS

Library of Congress Cataloging-in-Publication Data

CONTENTS

PREFACE

Chapter 1: IT TAKES A VILLAGE TO CARE FOR ATTENTION DEFICIT/HYPERACTIVITY DISORDER: IMPROVING MANAGEMENT COLLABORATION BETWEEN TERTIARY CARE CENTERS AND THE COMMUNITY

ABSTRACT

INTRODUCTION

THE MANAGEMENT OF ADHD IN PRIMARY CARE PRACTICE

IMPROVING THE ADHERENCE TO AAP GUIDELINES IN THE COMMUNITY PRACTICE

CONCLUSION

REFERENCES

Chapter 2: THE TEEN COG-FUN MODEL OF INTERVENTION FOR ADOLESCENTS WITH ADHD

ABSTRACT

INTRODUCTION: ADHD AND ADOLESCENCE

HYPOTHESIZED ENABLING FACTORS

SUMMARY AND CONCLUSION

REFERENCES

Chapter 3: GIFTEDNESS AND ADHD

ABSTRACT

GIFTEDNESS

ADHD

CLINICAL ISSUES

COMPARISON

SUMMARY OF THE CLINICAL PICTURE

TREATMENT

CONCLUSION

REFERENCES

Chapter 4: THE RELATIONSHIP BETWEEN ADHD AND SMD

ABSTRACT

ATTENTION DEFICIT HYPERACTIVITY DISORDER

SENSORY MODULATION DISORDER

COMORBIDITY: ADHD AND SMD

PREVALENCE OF ADHD/SMD

SENSORY PROFILES OF CHILDREN WITH ADHD

DIFFERENTIATING SMD FROM ADHD

DISCUSSION

REFERENCES

Chapter 5: INTRAUTERINE GROWTH RETARDATION AND ADHD

ABSTRACT

DEFINITIONS

PATHOPHYSIOLOGY

EVIDENCE FOR AN ASSOCIATION BETWEEN ADHD AND IUGR

REFERENCES

Chapter 6: COGNITIVE FUNCTIONAL (COG-FUN)INTERVENTION FOR CHILDREN WITH ADHD: THEORY AND PRACTICE

ABSTRACT

INTRODUCTION

BIO-PSYCHO-SOCIAL IMPLICATIONS OF ADHD

THE COG-FUN MODEL

THE COG-FUN PROTOCOL

CASE STUDY

RESEARCH

CONCLUSION

REFERENCES

Chapter 7: ADHD AMONG CHILDREN WITH SIGNIFICANT DEVELOPMENTAL DELAY OR INTELLECTUAL DISABILITY

ABSTRACT

INTRODUCTION

ADHD IN DOWN SYNDROME

MEDICAL TREATMENT OF ADHD IN CHILDREN WITH DOWN SYNDROME

ADHD IN FRAGILE X SYNDROME (FXS)

TREATMENT OF ADHD SYMPTOMS IN FRAGILE X

ADHD IN 22Q11.2 DELETION SYNDROME

TREATMENT OF ADHD IN CHILDREN WITH 22Q11.2 DELETION

ADHD IN NEUROFIBROMATOSIS 1 (VON RECKLINGHAUSEN DISEASE)

TREATMENT OF ADHD IN NF1

RISPERIDONE FOR CHILDREN WITH ID AND ADHD DISRUPTIVE BEHAVIOUR

CONCLUSION

REFERENCES

Chapter 8: DSM-5, CONNECTIVITY AND NEUROPATHOLOGY: ADHD AND AUTISM AS AN EXAMPLE

ABSTRACT

INTRODUCTION

NETWORK BIOLOGY- A NEW CONCEPT

THE BRAIN MAPPING

HIERARCHY AND RELATIONS OF BRAIN NETWORKS

RELATION OF THE CLINICAL GUIDE (DSM-5) AND SCIENCE

DSM-5 NEW APPROACH: ASD AND ADHD AS AN EXAMPLE

CONCLUSION

REFERENCES

Chapter 9: ATTENTION DEFICIT HYPERACTIVITY DISORDER AMONG CHILDREN WITH CHRONIC DISEASES

ABSTRACT

INTRODUCTION

GENERAL CONCEPTS

DIABETES MELLITUS (DM)

EPILEPSY

HEADACHE

ALLERGIC/ATOPIC CONDITIONS AND ASTHMA

CELIAC

CHRONIC KIDNEY DISEASE

CANCER

CHRONIC/CONGENITAL HEART DISEASE

SUMMARY

REFERENCES

Chapter 10: ATTENTION-DEFICIT/HYPERACTIVITY DISORDER AND SUBSTANCE USE DISORDERS

ABSTRACT

INTRODUCTION

ATTENTION DEFICIT/HYPERACTIVITY DISORDER

ETIOLOGY

LONG TERM OUTCOME OF ADHD

SUBSTANCE USE DISORDERS

PREVALENCE

THE LINKAGE BETWEEN ADHD AND SUD

TREATMENT OF PATIENTS WITH ADHD AND SUD

PREVENTION OF SUD DEVELOPMENT IN ADHD CHILDREN AND ADOLESCENTS

CONSEQUENSES FOR CLINICAL PRACTICE

CONCLUSION

REFERENCES

EDITORS’ CONTACT INFORMATION

INDEX